Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Aqtual to Present Poster at American Association for Cancer Research Annual Meeting 2024 | ||
| By: PR Newswire Association LLC. - 27 Mar 2024 | Back to overview list |
|
|
Study highlights the potential for active chromatin cell-free DNA analysis to impact applications across precision oncology HAYWARD, Calif., March 27, 2024 /PRNewswire/ -- Aqtual, Inc., a precision medicine company using its novel cell-free DNA platform to develop products for chronic diseases and oncology, today announced that it will present a poster at the American Association for Cancer Research (AACR) Annual Meeting, held April 5-10, 2024, in San Diego, California.
"We have developed a plasma-based active chromatin capture method designed to capture both disease- and organ-specific molecular signals through a routine blood test," said Diana Abdueva, Ph.D., co-founder and CEO of Aqtual. "Our unique ability to analyze cell-free DNA derived from active chromatin enables comprehensive analysis of the epigenetic and transcriptomic landscape of both the tumor and immune components, providing novel insights that could help guide therapy selection and advance precision medicine." Details of the poster presentation are as follows:
About Aqtual, Inc.
SOURCE Aqtual 
|
||
|
||
 | Back to overview list | |
View original content to download multimedia: